Biomolecular and Clinical Aspects of Traditional Medicine
Biomolecular research studies how traditional medicines act inside the body, from the compounds they contain to the genes, proteins and pathways they affect. Clinical research then tests whether these effects lead to real benefits for patients.
The Biomolecular and Clinical Aspects of Traditional Medicine session at GSTIM 2027 brings laboratory and clinical research together. It links closely with herbal medicine, phytotherapy, and medicinal plants, the source of many compounds studied in this field.
Traditional medicines often contain many active compounds that work together. Understanding these compounds helps explain both benefits and risks. Laboratory studies can point to which remedies deserve clinical testing. Linking lab and clinic is key to building strong evidence.
Key Topics in Biomolecular and Clinical Aspects of Traditional Medicine
• Active compounds and mechanisms of action
• Pharmacokinetics of traditional medicines
• Network pharmacology and systems biology
• Omics approaches in traditional medicine
• Cell and animal models
• Biomarkers of treatment response
• Toxicology and safety studies
• Herb–drug interactions at the molecular level
• Clinical pharmacology studies
• Linking mechanisms to clinical outcomes
Recent Advances in Biomolecular and Clinical Aspects of Traditional Medicine
Genomics, metabolomics and proteomics are revealing how complex herbal formulas affect many targets at once. Network pharmacology is being applied to Traditional Chinese Medicine: evidence and applications and to classical formulas from Ayurveda, Unani, Siddha, and traditional medical systems.
Biomarkers are helping researchers measure treatment response more precisely, supporting work in personalized and precision approaches in ethnomedicine. Mechanistic findings are also guiding the design of better clinical trials.
Omics and computer modelling are mapping how herbal formulas affect many targets at once. Researchers are studying how compounds are absorbed and broken down in the body. Toxicology studies are improving safety. These methods are helping turn traditional knowledge into tested treatments.
Who Should Attend the Biomolecular and Clinical Aspects of Traditional Medicine Session
• Pharmacologists and molecular biologists
• Phytochemists and natural product researchers
• Clinical researchers and physicians
• Toxicologists and safety scientists
• Students and early-career researchers
• Pharmaceutical and nutraceutical R&D teams
Why Present Your Research in Biomolecular and Clinical Aspects of Traditional Medicine
Presenting at GSTIM 2027 connects your laboratory research with clinicians and traditional practitioners. You can share findings and meet colleagues in translational research and innovation in traditional medicine who help turn discoveries into treatments. Laboratory and clinical researchers meet in this session. Your work can help connect discoveries with patient care.
Frequently Asked Questions
Can I present cell or animal studies?
Yes. Preclinical studies with clear methods and ethical approval are welcome.
Does this session cover network pharmacology?
Yes. Network pharmacology and systems biology are key topics.
When and where is GSTIM 2027?
GSTIM 2027 takes place from 4 to 6 March 2027 at Village Hotel Changi, Singapore, and online.